top of page
Search Results

265 items found for "allosteric modulation"

  • 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!

    disturbances GPCR Binders, Drugs, and more Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors GPCRs in Neuroscience In-silico predicted mouse melanopsins with Caenorhabditis elegans Calcium-sensing receptor regulates Kv7 channels via Gi/o protein signalling and modulates antigens enable drug discovery and development Mapping GPCR-RAMP complexes with MolBoolean Screening GPR75 Modulators

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    A Rab10-ACAP1-Arf6 GTPases cascade modulates M4 muscarinic acetylcholine receptor trafficking and signaling Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator. α1-adrenoceptor Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    course covers fundamental pharmacology in four weekly segments, delving into Agonists, Antagonists, and Allosteric Modulators

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    5th to 11th, 2024 GPCR Activation and Signaling Constitutive activation mechanism of a class C GPCR Allosteric modulation and G-protein selectivity of the Ca2+-sensing receptor GPCRs in Cardiology, Endocrinology Research GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

  • Therapeutic validation of an orphan G protein‐coupled receptor

    IM (3,3′‐methylenebis‐1H‐indole) has been identified as a positive allosteric modulator of GPR84, a metabolite

  • 📰 GPCR Weekly News, May 8 to 14, 2023

    An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model

  • 📰 GPCR Weekly News, July 1 to 7, 2024

    for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic internalization of cognate GPCRs and disrupt downstream intracellular signaling Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders GPCRs in Cardiology, Endocrinology Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue Modulation cortex Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation

  • 📰 GPCR Weekly News, June 17 to 23, 2024

    G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model failure drug following reverse merger with Avrobio Addex Pharma unveils new mGlu7 receptor negative allosteric modulators Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates

  • 📰 GPCR Weekly News, February 20 to 26, 2023

    Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic

  • 📰 GPCR Weekly News, March 25 to March 31, 2024

    effects on mouse metabolism Mechanistic insights into sodium ion-mediated ligand binding affinity and modulation analysis Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation Excellence Awards Domain Therapeutics to Present Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology Crinetics Pharmaceuticals gets grant for patent granted for somatostatin modulators for treating hormone-related conditions Sosei Heptares Confirms Re-election of its Board

  • GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!

    Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. somatostatin receptors SSTR1 and SSTR3 SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor GPCR Binders, Drugs, and more Molecular glues as potential

  • Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures

    October 2022 "G protein-coupled receptors (GPCRs) are important drug targets characterized by a canonical seven transmembrane (TM) helix architecture. Recent advances in X-ray crystallography and cryo-EM have resulted in a wealth of GPCR structures that have been used in drug design and formed the basis for mechanistic activation hypotheses. Here, ensemble refinement (ER) of crystallographic structures is applied to explore the impact of binding of agonists and antagonist/inverse agonists to selected structures of cannabinoid receptor 1 (CB1R), β2 adrenergic receptor (β2 AR) and A2A adenosine receptor (A2A AR). " Read more at the source #DrGPCR #GPCR #IndustryNews

  • Mechanism of enhanced sensitivity of mutated β-adrenergic-like octopamine receptor to amitraz in...

    October 2022 Mechanism of enhanced sensitivity of mutated β-adrenergic-like octopamine receptor to amitraz in honeybee Apis mellifera: An insight from MD simulations "Background: Amitraz is one of the critical acaricides/insecticides for effective control of pest infestation of Varroa destructor mite, a devastating parasite of Apis mellifera, because of its low toxicity to honeybees. Previous assays verified that a typical G protein-coupled receptor, β-adrenergic-like octopamine receptor (Octβ2R), is the unique target of amitraz, but the honeybee Octβ2R resists to amitraz. However, the underlying molecular mechanism of the enhanced sensitivity or toxicity of amitraz to mutated honeybee Octβ2RE208V/I335T/I350V is not fully understood. Here, molecular dynamics simulations are employed to explore the implied mechanism of the enhanced sensitivity to amitraz in mutant honeybee Octβ2R." Read more at the source #DrGPCR #GPCR #IndustryNews

  • TLR4 biased small molecule modulators

    Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic Therefore, the identification of such modulators as drug candidates is highly desirable. The biased signaling modulation of non-GPCR receptors has yet to be exploited. The challenges and methods for the discovery of TLR4 biased modulators are also outlined. modulators for other non-GPCR receptors.

  • Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors

    Although many cardiovascular GPCRs have been extensively studied as model receptors for decades, new As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation

  • The development of modulators for lysophosphatidic acid receptors: A comprehensive review

    provides an extensive review on the current status of ligand development targeting LPA receptors to modulate

  • Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization

    However, reorganization of the actin cytoskeleton upon modulation of membrane cholesterol and its consequences crucial neurotransmitter G protein-coupled receptor (GPCR) that plays a major role in the generation and modulation indicate that lateral diffusion parameters of serotonin1A receptors in normal cells are consistent with models On a broader perspective, these results assume significance in understanding the modulatory role of the

  • Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist

    work at SIRS2022 confirming the ability of the highly selective novel GPR52 agonist HTL00411718 to modulate

  • Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...

    July 2022 Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators

  • TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi

    Likewise, in this work the authors identify for the first time the specific amino acids that modulate

  • Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder

    Modulating a single function of a specific aGPCR isoform while affecting no other function and no other Our work provides proof of concept for the modulation of isoform- and ligand specific aGPCR functions

  • Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms

    can regulate GPCR/14-3-3 signals temporally, suggesting a new approach for GPCR drug development by modulating

  • Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2

    In the current report we present evidence of the modulation of PK2/PKR2 activity by anosmin 1, since The whey acidic protein domain (WAP) is necessary for this modulatory activity, although data from GST cysteine-rich (CR) and the FnIII.1 domains could assist the WAP domain both in the binding to PKR2 and in the modulation Our data support the idea of a modulatory role of anosmin 1 in the biological effects controlled by the

  • Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids

    We demonstrate how tail composition plays a role in modulating the binding of PI(4,5)P2 lipids to GCGR

  • Identification of GPCRs Modulating Flow-induced Signaling Pathways in Vascular Endothelial Cells

    Join us for the first virtual cafe talk to hear about the amazing work that Dr. Brian Arey is doing. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...

    September 2022 Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer "Quantitative systems pharmacology (QSP) modeling is immuno-suppressive tumor microenvironment, we incorporated the dynamics of TAMs into our previously published QSP model We show that through proper calibration, the model captures the macrophage heterogeneity in the tumor Despite its high mechanistic complexity, the modularized QSP platform can be readily reproduced, expanded

  • Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of...

    October 2022 Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use Although the overall accuracy of the two non-homology-based modeling methods, AlphaFold and RoseTTAFold for GPCRs with the most widely used template-based software-Modeller. If only looking at each program's top-scored structure, Modeller had the smallest average modeling RMSD 73 cases with the top-scored model, respectively, where no good templates were available for Modeller

bottom of page